Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Methimazole

CompanyPreferred Pharmaceuticals Inc. (DUNS: 791119022)

Effective Date

August 2, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Methimazole(5 mg in 1 1)

Registrants (1)

Preferred Pharmaceuticals Inc.

DUNS Number

791119022

Manufacturing Establishments (1)

Preferred Pharmaceuticals Inc.

Labeler

Preferred Pharmaceuticals Inc.

Registrant

Preferred Pharmaceuticals Inc.

DUNS Number

791119022

Products (1)

Methimazole

NDC Product Code

68788-8226

Application Number

ANDA040734

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

August 2, 2023

Ingredients

MethimazoleActive

Code: 554Z48XN5EClass: ACTIBQuantity: 5 mg in 1 1

LACTOSE MONOHYDRATEInactive

Code: EWQ57Q8I5XClass: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

STARCH, CORNInactive

Code: O8232NY3SJClass: IACT

TALCInactive

Code: 7SEV7J4R1UClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy